Utidelone has the ability to cross BBB due to its unique physicochemical characteristic and insusceptibility to P-glycoprotein-mediated efflux
Immune-mediated events and infusion reactions were higher with KEYTRUDA (38% vs 9%, respectively).
Restasis has been approved for use in the U.S. for nearly 20 years, but until today, there was no approved generic product of this drug
The Stasis connected care monitoring system includes - a bedside monitor that monitors 6 vital signs, a tablet that enables intuitive monitoring, and the Stasis app that allows for remote monitoring across devices
This program aims to develop a fully human monoclonal antibody against a novel immune checkpoint protein that enables T cell activation
Imfinzi reduced the risk of distant metastases and death from bladder cancer vs. neoadjuvant chemotherapy alone
HYMPAVZI’s approval is based on Phase 3 study results demonstrating substantial bleed reduction compared to routine prophylaxis
PiaSky advances C5 inhibition through innovative recycling technology, which enables its monthly SC administration
The study highlighted substantial improvements in key clinical parameters among RA patients who underwent AWS intervention
PiaSky advances C5 inhibition through innovative recycling technology, which enables its monthly SC administration
Subscribe To Our Newsletter & Stay Updated
